Positive volume growth was observed in key therapies such as respiratory (13.2% yoy), anti-neoplastics (12.1% yoy) and cardiac (4.8% yoy) during September 2025
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Datroway becomes the first and only therapy to show overall survival benefit versus chemotherapy in this difficult-to-treat patient population
Medico Remedies receives order worth US$ 1,781,000
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Subscribe To Our Newsletter & Stay Updated
